We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $23.2B
1-Year Est. Return 40.19%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$50.9B
AUM Growth
+$1.3B
Cap. Flow
-$1.07B
Cap. Flow %
-2.1%
Top 10 Hldgs %
15.25%
Holding
1,701
New
146
Increased
583
Reduced
501
Closed
151

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$79.4M
2
CVS icon
CVS Health
CVS
+$68M
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$55.3M
4
UBS icon
UBS Group
UBS
+$54.6M
5
INTC icon
Intel
INTC
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 17.25%
2 Financials 13.82%
3 Industrials 11.25%
4 Technology 10.93%
5 Energy 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
1
AT&T
T
$176B
$798M 1.57%
24,459,017
+104,070
+0.4% +$3.1M
HAL icon
2
Halliburton
HAL
$30.9B
$792M 1.55%
17,477,865
-1,291,510
-7% -$53.1M
EIX icon
3
Edison International
EIX
$21.8B
$791M 1.55%
10,185,545
-247,065
-2% -$17.7M
PFE icon
4
Pfizer
PFE
$162B
$786M 1.54%
23,531,137
+58,904
+0.3% +$1.88M
JNJ icon
5
Johnson & Johnson
JNJ
$663B
$786M 1.54%
6,480,273
-115,905
-2% -$13.2M
VZ icon
6
Verizon
VZ
$208B
$783M 1.54%
14,029,001
+650,267
+5% +$33.7M
DGX icon
7
Quest Diagnostics
DGX
$26.2B
$769M 1.51%
9,449,405
-447,236
-5% -$34.1M
WM icon
8
Waste Management
WM
$87.5B
$764M 1.5%
11,521,184
-168,628
-1% -$10.2M
ADM icon
9
Archer Daniels Midland
ADM
$40.8B
$753M 1.48%
17,552,154
-243,050
-1% -$9.69M
INTC icon
10
Intel
INTC
$506B
$743M 1.46%
22,660,904
+1,690,347
+8% +$53M
KHC icon
11
Kraft Heinz
KHC
$29.5B
$741M 1.46%
8,376,251
-204,661
-2% -$16.8M
CVX icon
12
Chevron
CVX
$409B
$741M 1.45%
7,067,285
-250,587
-3% -$25.2M
MDLZ icon
13
Mondelez International
MDLZ
$78.2B
$740M 1.45%
16,256,406
+128,759
+0.8% +$5.61M
CVS icon
14
CVS Health
CVS
$124B
$738M 1.45%
7,707,523
+682,784
+10% +$68M
NOC icon
15
Northrop Grumman
NOC
$73.2B
$737M 1.45%
3,316,885
-184,497
-5% -$38.8M
LOW icon
16
Lowe's Companies
LOW
$115B
$737M 1.45%
9,311,165
-53,555
-0.6% -$4.14M
MRK icon
17
Merck
MRK
$371B
$733M 1.44%
13,338,617
+148,218
+1% +$7.89M
ALL icon
18
Allstate
ALL
$65.6B
$732M 1.44%
10,458,406
+296,985
+3% +$19.9M
JCI icon
19
Johnson Controls International
JCI
$87.8B
$730M 1.43%
15,759,899
-217,225
-1% -$9.57M
MRSH
20
Marsh
MRSH
$88.6B
$730M 1.43%
10,662,019
-696,551
-6% -$44.7M
CSCO icon
21
Cisco
CSCO
$431B
$729M 1.43%
25,399,541
-38,531
-0.2% -$1.08M
CA
22
DELISTED
CA, Inc.
CA
$726M 1.43%
22,107,439
+77,866
+0.4% +$2.44M
ESRX
23
DELISTED
Express Scripts Holding Company
ESRX
$720M 1.41%
9,500,765
-49,554
-0.5% -$3.64M
OXY icon
24
Occidental Petroleum
OXY
$60B
$718M 1.41%
9,505,449
+70,978
+0.8% +$5.3M
TFC icon
25
Truist Financial
TFC
$63.1B
$713M 1.4%
20,026,105
+1,289,115
+7% +$45M

Similar funds

Macquarie Group's Q2 2016 Portfolio in Review

As of Q2 2016, Macquarie Group held 1,701 positions worth $50.9B, up 2.6% from $49.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2016 filing shows 146 new, 583 increased, 501 reduced and 151 closed positions. Its largest new stake was iShares Russell 2000 Value ETF: 580,847 shares worth $56.5M. The largest sale was BAXALTA INC COM STK (DE), an estimated $737M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

  • Macquarie Group's largest Q2 2016 buy was iShares Russell 2000 Value ETF: 580,847 shares worth $56.5M.
  • Macquarie Group added most to Cardinal Health in Q2 2016, an estimated $79.4M increase.
  • Macquarie Group's biggest Q2 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $737M.
  • Macquarie Group fully exited Bausch Health in Q2 2016, selling an estimated $71M.
  • Macquarie Group's ten largest holdings make up 15% of its $50.9B portfolio in Q2 2016.
  • Macquarie Group opened 146 new positions and closed 151 in Q2 2016.
  • Macquarie Group's portfolio value rose 2.6% quarter-over-quarter to $50.9B.

Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.